Measles, Mumps, and Rubella Booster Immunization Practices
National Technical Information Service; 2020.
Non-conventional
in English
| National Technical Information Service | ID: grc-753590
ABSTRACT
Reported cases of mumps infection in the United States (U.S.) have dropped since the introduction of the single-component mumps vaccine in 1967. After introduction of the multi-component measles, mumps, rubella (MMR) vaccine, cases in the U.S. and worldwide fell to the point where the International Task Force for Disease Eradication identified mumps for eventual global eradication. By 1991, all military recruits received an MMR vaccine. By 2010, the Department of Defense (DoD) had adopted a policy of immunizing recruits with MMR vaccine only if their antibody titers to measles or rubella had dropped below threshold levels established by the commercial testing laboratories as indicative of immunity. As part of a 2010 Defense Health Board (DHB) review of MMR immunization practices by the Department of the Navy, the DHB recommended that the Navy continue the practice of MMR immunization based on serosurveillance, but that universal MMR vaccination be re-instituted in the event of an increased risk of a mumps outbreak.
COVID-19; CORONAVIRUSES; DISEASE OUTBREAKS; IMMUNIZATION; MILITARY PERSONNEL; VACCINES; RISK ANALYSIS; MILITARY MEDICINE; QUARANTINE; NAVAL VESSELS; ANTIBODIES; MEDICAL SCREENING; RUBELLA; IMMUNITY; NAVY; VIROLOGY; PUBLIC HEALTH; Mmr(measles mumps and rubella); Mmr booster immunization practices; Sars-cov-19; Sars-cov-2(severe acute respiratory syndrome coronavirus 2); Operational impact
Full text:
Available
Collection:
Databases of international organizations
Database:
National Technical Information Service
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Year:
2020
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS